Description:

KS Evaluation and Clinical Benefit Form: RK1 NCT00310128 Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0059EF25-C95F-0C32-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0059EF25-C95F-0C32-E044-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 1/9/15
  3. 6/21/15
Uploaded on:

June 21, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

KS Evaluation and Clinical Benefit Form: RK1 NCT00310128

No Instruction available.

  1. StudyEvent: KS Evaluation and Clinical Benefit Form: RK1
    1. No Instruction available.
Patient demographics
History And Symptoms
Evaluation Of Cutaneous Lesions
Evaluation Of Marker Lesions
Evaluation Of Foot Ks
Evaluation Of Oral Cavity
%
Lesions Measurements
cm
cm
Edema Evaluation
Evaluation Of Extremity Edema
Evaluation Of Periorbital Edema
Evaluation Of Scrotal/genital Swelling
Evaluation Of Visceral Disease
Interventions (in Addition To Study Drug Therapy)
Overall Assessment